Ries Kranse

Summary

Affiliation: Helen Dowling Institute
Country: The Netherlands

Publications

  1. ncbi request reprint Pre-selection of patients for pressure-flow analysis based on the maximum flow rate
    Ries Kranse
    Department of Urology, Erasmus University Rotterdam, Urodynamics Room Ee1630, P O Box 1738, 3000 DR Rotterdam, The Netherlands
    Eur Urol 42:506-15. 2002
  2. doi request reprint A graphical device to represent the outcomes of a logistic regression analysis
    Ries Kranse
    Rotterdam Cancer Registry, Rotterdam, The Netherlands
    Prostate 68:1674-80. 2008
  3. doi request reprint Screening for prostate cancer: results of the Rotterdam section of the European randomized study of screening for prostate cancer
    Monique J Roobol
    Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands
    Eur Urol 64:530-9. 2013
  4. doi request reprint A risk-based strategy improves prostate-specific antigen-driven detection of prostate cancer
    Monique J Roobol
    Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands
    Eur Urol 57:79-85. 2010
  5. doi request reprint Towards an optimal interval for prostate cancer screening
    Pim J van Leeuwen
    Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands
    Eur Urol 61:171-6. 2012
  6. ncbi request reprint Impacts of a population-based prostate cancer screening programme on excess total mortality rates in men with prostate cancer: a randomized controlled trial
    Pim J van Leeuwen
    Erasmus University MedicalCentre, Rotterdam, The Netherlands
    J Med Screen 20:33-8. 2013
  7. ncbi request reprint Overestimation of prostate cancer mortality and other-cause mortality by the Kaplan-Meier method
    Xiaoye Zhu
    Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands
    Can J Urol 20:6756-60. 2013
  8. doi request reprint Excess all-cause mortality in the evaluation of a screening trial to account for selective participation
    Ries Kranse
    Department of Urology, Erasmus Medical Centre, Rotterdam, The Netherlands and Comprehensive Cancer Center the Netherlands IKNL, Utrecht, The Netherlands
    J Med Screen 20:39-45. 2013
  9. ncbi request reprint Metastatic disease of screen-detected prostate cancer : characteristics at diagnosis
    Stijn Roemeling
    Department of Urology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands
    Cancer 107:2779-85. 2006
  10. doi request reprint Prospective validation of a risk calculator which calculates the probability of a positive prostate biopsy in a contemporary clinical cohort
    Heidi A van Vugt
    Department of Urology, Erasmus Medical Center, Rotterdam, The Netherlands
    Eur J Cancer 48:1809-15. 2012

Collaborators

Detail Information

Publications27

  1. ncbi request reprint Pre-selection of patients for pressure-flow analysis based on the maximum flow rate
    Ries Kranse
    Department of Urology, Erasmus University Rotterdam, Urodynamics Room Ee1630, P O Box 1738, 3000 DR Rotterdam, The Netherlands
    Eur Urol 42:506-15. 2002
    ..In addition, the variables on which these effects depend are studied...
  2. doi request reprint A graphical device to represent the outcomes of a logistic regression analysis
    Ries Kranse
    Rotterdam Cancer Registry, Rotterdam, The Netherlands
    Prostate 68:1674-80. 2008
    ..Both models mentioned above are logistic regression models. Nomograms enable their use in daily clinical practice...
  3. doi request reprint Screening for prostate cancer: results of the Rotterdam section of the European randomized study of screening for prostate cancer
    Monique J Roobol
    Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands
    Eur Urol 64:530-9. 2013
    ..Evidence from randomized trials on the effects of screening for prostate cancer (PCa) on disease-specific mortality accumulates slowly with increasing follow-up...
  4. doi request reprint A risk-based strategy improves prostate-specific antigen-driven detection of prostate cancer
    Monique J Roobol
    Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands
    Eur Urol 57:79-85. 2010
    ..Screening for prostate cancer (PC) is controversial due to uncertainties about its efficiency...
  5. doi request reprint Towards an optimal interval for prostate cancer screening
    Pim J van Leeuwen
    Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands
    Eur Urol 61:171-6. 2012
    ..The rate of decrease in advanced cancers is an estimate for determining prostate cancer (PCa) screening program effectiveness...
  6. ncbi request reprint Impacts of a population-based prostate cancer screening programme on excess total mortality rates in men with prostate cancer: a randomized controlled trial
    Pim J van Leeuwen
    Erasmus University MedicalCentre, Rotterdam, The Netherlands
    J Med Screen 20:33-8. 2013
    ..To assess the effect of screening in terms of excess mortality in the European Randomized Study of Screening for Prostate Cancer (ERSPC)...
  7. ncbi request reprint Overestimation of prostate cancer mortality and other-cause mortality by the Kaplan-Meier method
    Xiaoye Zhu
    Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands
    Can J Urol 20:6756-60. 2013
    ..To assess the extent of overestimation of the cumulative probability of death by the Kaplan-Meier method with the competing-risks regression analysis as reference approach...
  8. doi request reprint Excess all-cause mortality in the evaluation of a screening trial to account for selective participation
    Ries Kranse
    Department of Urology, Erasmus Medical Centre, Rotterdam, The Netherlands and Comprehensive Cancer Center the Netherlands IKNL, Utrecht, The Netherlands
    J Med Screen 20:39-45. 2013
    ..We studied the effect of not accounting for attendance on the calculated excess mortality in a prostate cancer screening trial...
  9. ncbi request reprint Metastatic disease of screen-detected prostate cancer : characteristics at diagnosis
    Stijn Roemeling
    Department of Urology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands
    Cancer 107:2779-85. 2006
    ..Risk stratification of screen-detected cancers at diagnosis has become more important for the anticipation and interpretation of changing incidence/mortality ratios...
  10. doi request reprint Prospective validation of a risk calculator which calculates the probability of a positive prostate biopsy in a contemporary clinical cohort
    Heidi A van Vugt
    Department of Urology, Erasmus Medical Center, Rotterdam, The Netherlands
    Eur J Cancer 48:1809-15. 2012
    ..Prediction models need validation to assess their value outside the development setting...
  11. ncbi request reprint Causes for variability in repeated pressure-flow measurements
    Ries Kranse
    Department of Urology, Division of Urodynamics, Erasmus University Rotterdam, Rotterdam, The Netherlands
    Urology 61:930-4; discussion 934-5. 2003
    ..Because of the central role of Qmax and PdetQmax in the diagnosis of bladder outlet obstruction, this is reason for concern...
  12. ncbi request reprint A comparison of first and repeat (four years later) prostate cancer screening in a randomized cohort of a symptomatic men aged 55-75 years using a biopsy indication of 3.0 ng/ml (results of ERSPC, Rotterdam)
    Monique J Roobol
    Department of Urology, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands
    Prostate 66:604-12. 2006
    ..The identification of predictors for prostate biopsy outcome at two screening rounds using a PSA>or=3.0 ng/ml as biopsy indication...
  13. doi request reprint Increased non-prostate cancer death risk in clinically diagnosed prostate cancer
    Pim J van Leeuwen
    Department of Urology Public Health, Erasmus Medical Centre, Rotterdam Cancer Registry Rotterdam, Rotterdam, The Netherlands
    BJU Int 110:188-94. 2012
    ..Men with clinically diagnosed PC have an increased risk of death unrelated to PC itself, i.e., the excess mortality is based on an increased risk of dying from other neoplasm and diseases of the circulatory or respiratory system...
  14. doi request reprint Prediction of prostate cancer in unscreened men: external validation of a risk calculator
    Heidi A van Vugt
    Department of Urology, Erasmus Medical Center, Rotterdam, The Netherlands
    Eur J Cancer 47:903-9. 2011
    ..Prediction models need external validation to assess their value beyond the setting where the model was derived from...
  15. pmc The additional value of TGFβ1 and IL-7 to predict the course of prostate cancer progression
    Caroline Schroten
    Department of Urology, Erasmus MC, Gravendijkwal 230, Rotterdam, The Netherlands
    Cancer Immunol Immunother 61:905-10. 2012
    ....
  16. ncbi request reprint Does PSA velocity predict prostate cancer in pre-screened populations?
    Fritz H Schroder
    Department of Urology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands
    Eur Urol 49:460-5; discussion 465. 2006
    ..An elevated PSA in secondary screens may indicate benign enlargement of the prostate rather than prostate cancer. In such cases the yearly rate of increase of PSA (PSA velocity [PSAV]) may improve the test characteristics of PSA...
  17. ncbi request reprint Weak correlation between bladder outlet obstruction and probability to void to completion
    Ries Kranse
    Comprehensive Cancer Center, Rotterdam, The Netherlands
    Urology 62:667-71. 2003
    ..To investigate the weak correlation between bladder outlet obstruction (BOO), as diagnosed using the provisional International Continence Society nomogram for the definition of BOO in men, and postvoid residual urine volume...
  18. doi request reprint Disease-specific mortality may underestimate the total effect of prostate cancer screening
    Pim J van Leeuwen
    Erasmus University Medical Centre, Rotterdam, The Netherlands
    J Med Screen 17:204-10. 2010
    ..To study the difference between the disease-specific and excess mortality rate in the European Randomized Study of Screening for Prostate Cancer section Rotterdam...
  19. ncbi request reprint Should we replace the Gleason score with the amount of high-grade prostate cancer?
    Andre N Vis
    Department of Urology, Erasmus Medical Center, Rotterdam, The Netherlands
    Eur Urol 51:931-9. 2007
    ..We investigated the predictive value of the amount of high-grade cancer (Gleason growth patterns 4/5) in the biopsy for prostate-specific antigen (PSA) and clinical relapse after radical prostatectomy...
  20. ncbi request reprint Dietary intervention in prostate cancer patients: PSA response in a randomized double-blind placebo-controlled study
    Ries Kranse
    Department of Urology, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands
    Int J Cancer 113:835-40. 2005
    ..If future studies confirm that these observations translate into a slowing of disease progression, a dietary intervention may become an attractive option for prostate cancer treatment and prevention...
  21. doi request reprint The incidence and risk factors of metachronous colorectal cancer: an indication for follow-up
    Sanna A Mulder
    Department of Gastroenterology and Hepatology, Erasmus University Medical Centre, Rotterdam, The Netherlands
    Dis Colon Rectum 55:522-31. 2012
    ..Patients with colorectal cancer are at risk for developing metachronous colorectal cancer. The purpose of posttreatment surveillance is to detect and remove premalignant lesions to prevent metachronous colorectal cancer...
  22. ncbi request reprint Relative bladder outlet obstruction
    Ries Kranse
    Department of Urology Urodynamics, Erasmus University Rotterdam, Rotterdam, The Netherlands
    J Urol 168:565-70. 2002
    ..Recently there has been some interest in the development of a similar nomogram for females...
  23. ncbi request reprint Bladder outlet resistance
    Ries Kranse
    Department of Urology Urodynamics, Erasmus University Rotterdam, The Netherlands
    J Urol 169:1007-10. 2003
    ..We developed a method to objectively compare methods for the quantification of bladder outlet resistance...
  24. ncbi request reprint Prostate cancer characteristics and prostate specific antigen changes in screening detected patients initially treated with a watchful waiting policy
    Stijn H de Vries
    Department of Urology, Erasmus Medical Center and Comprehensive Cancer Center, Rotterdam, The Netherlands
    J Urol 172:2193-6. 2004
    ..We evaluated prostate cancer (PCa) characteristics at diagnosis and changes in prostatic specific antigen (PSA) with time in males with screening detected PCa that was initially managed with a watchful waiting policy...
  25. ncbi request reprint A more advanced clinical stage is positively correlated with an increased prostate cancer detection rate
    Monique J Roobol
    Department of Urology, Dijkzigt Academic Hospital, Rotterdam, The Netherlands
    Urology 59:91-6. 2002
    ..A suspicious digital rectal examination (DRE) and/or a suspicious transrectal ultrasound (TRUS) investigation increases the likelihood of prostate cancer given a certain prostate-specific antigen level...
  26. ncbi request reprint Large-scale randomized prostate cancer screening trials: program performances in the European Randomized Screening for Prostate Cancer trial and the Prostate, Lung, Colorectal and Ovary cancer trial
    Harry J de Koning
    Department of Public Health, Erasmus University Rotterdam, PO Box 1738, 3000 DR Rotterdam, The Netherlands
    Int J Cancer 97:237-44. 2002
    ..The differences between countries seem to reflect both underlying prostate cancer incidence and screening policy. The trials have the power to show definitive results in 2005-2008...
  27. ncbi request reprint Verification bias and the prostate-specific antigen test--is there a case for a lower threshold for biopsy?
    Fritz H Schroder
    N Engl J Med 349:393-5. 2003